Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danbi Lee

Showing results (101-110 of 181) with videos related to

Pageof 19
Sort By:
Liver Cancer|April 21, 2025
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular CarcinomaJiwon Yang, Won-Mook Choi, Hyung-Don Kim, et al.
Clinical and Molecular Hepatology|July 11, 2020
Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trialSang Min Yoon, So Yeon Kim, Young-Suk Lim, et al.
Journal of Hepatology|December 3, 2014
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillanceGi-Ae Kim, Han Chu Lee, Min-Ju Kim, et al.
Medicine|July 30, 2016
Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South KoreaDo Young Kim, Ki Tae Yoon, Won Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|December 11, 2025
Transarterial Chemoembolization Alone Versus Combined With Radiation Therapy as First-Line Therapy for Early-Stage Single Hepatocellular CarcinomaHye In Lee, Jinhong Jung, So Yeon Kim, et al.
Journal of Liver Cancer|April 3, 2024
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinomaJiwon Yang, Won-Mook Choi, Danbi Lee, et al.
Gut|October 29, 2013
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durabilityGi-Ae Kim, Young-Suk Lim, Jihyun An, et al.
Digestive Diseases (Basel, Switzerland)|December 22, 2012
Effect of response to interferon-α therapy on the occurrence of hepatocellular carcinoma in patients with chronic hepatitis BDanbi Lee, Young-Hwa Chung, Sae Hwan Lee, et al.
Oncology|January 25, 2012
Transforming growth factor beta 1 overexpression is closely related to invasiveness of hepatocellular carcinomaDanbi Lee, Young-Hwa Chung, Jeong A Kim, et al.
Human Reproduction (Oxford, England)|August 7, 2021
Three-dimensional microengineered vascularised endometrium-on-a-chipJungho Ahn, Min-Ji Yoon, Seon-Hwa Hong, et al.
Pageof 19

Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
Liver Cancer|April 21, 2025
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular CarcinomaJiwon Yang, Won-Mook Choi, Hyung-Don Kim, et al.
Clinical and Molecular Hepatology|July 11, 2020
Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trialSang Min Yoon, So Yeon Kim, Young-Suk Lim, et al.
Journal of Hepatology|December 3, 2014
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillanceGi-Ae Kim, Han Chu Lee, Min-Ju Kim, et al.
Medicine|July 30, 2016
Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South KoreaDo Young Kim, Ki Tae Yoon, Won Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|December 11, 2025
Transarterial Chemoembolization Alone Versus Combined With Radiation Therapy as First-Line Therapy for Early-Stage Single Hepatocellular CarcinomaHye In Lee, Jinhong Jung, So Yeon Kim, et al.
Journal of Liver Cancer|April 3, 2024
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinomaJiwon Yang, Won-Mook Choi, Danbi Lee, et al.
Gut|October 29, 2013
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durabilityGi-Ae Kim, Young-Suk Lim, Jihyun An, et al.
Digestive Diseases (Basel, Switzerland)|December 22, 2012
Effect of response to interferon-α therapy on the occurrence of hepatocellular carcinoma in patients with chronic hepatitis BDanbi Lee, Young-Hwa Chung, Sae Hwan Lee, et al.
Oncology|January 25, 2012
Transforming growth factor beta 1 overexpression is closely related to invasiveness of hepatocellular carcinomaDanbi Lee, Young-Hwa Chung, Jeong A Kim, et al.
Human Reproduction (Oxford, England)|August 7, 2021
Three-dimensional microengineered vascularised endometrium-on-a-chipJungho Ahn, Min-Ji Yoon, Seon-Hwa Hong, et al.
Pageof 19